Proliferative Diabetic Retinopathy (PDR) Terminated Phase 3 Trials for Octreotide (DB00104)
Also known as: PDR - Proliferative Diabetic Retinopathy / Diabetic Proliferative Retinopathy / Proliferative Diabetic Retinopathy / Proliferative retinopathy due to diabetes mellitus (disorder) / Retinopathy due to diabetes mellitus (disorder) / Diabetic retinopathy / Retinopathy diabetic
| Indication | Status | Phase |
|---|---|---|
| DBCOND0056889 (Proliferative Diabetic Retinopathy (PDR)) | Terminated | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00170742 | Study to Assess the Efficacy and Safety of Monthly Octreotide Intramuscular Injections in Patients With Proliferative Diabetic Retinopathy After Lasercoagulation This Study is Not Being Conducted in the United States. | Treatment |